These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37114301)

  • 1. Correlation between Extracellular Matrix Metalloproteinase Inducer in Peripheral Blood and Serum MMPs in patients with Acute Coronary Syndrome.
    Wang W
    Cell Mol Biol (Noisy-le-grand); 2022 Nov; 68(11):97-104. PubMed ID: 37114301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between atherosclerotic plaque characteristics and extracellular matrix metalloproteinase inducer and urokinase-type plasminogen activator in patients with coronary artery disease].
    Yang L; Tian X; Guo R; Liu H; Qi F; Ye J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Sep; 42(9):740-3. PubMed ID: 25511093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of leukotriene b4 and extracellular matrix metalloproteinase inducer in acute coronary syndrome.
    Xu S; Tang L; Mi Y; Jiang J; Zhu M; Chen B; Wang B; Li T; Xu C; Wang J; Lu X; Ge W; Wang L; Huang J
    Clin Invest Med; 2013 Dec; 36(6):E282-9. PubMed ID: 24309224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes.
    Schmidt R; Bültmann A; Fischel S; Gillitzer A; Cullen P; Walch A; Jost P; Ungerer M; Tolley ND; Lindemann S; Gawaz M; Schömig A; May AE
    Circ Res; 2008 Feb; 102(3):302-9. PubMed ID: 18048771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.
    Schmidt R; Bültmann A; Ungerer M; Joghetaei N; Bülbül O; Thieme S; Chavakis T; Toole BP; Gawaz M; Schömig A; May AE
    Circulation; 2006 Feb; 113(6):834-41. PubMed ID: 16461815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of extracellular matrix metalloproteinase inducer glycosylation in regulating matrix metalloproteinases in periodontitis.
    Zhang Z; Yang X; Zhang H; Liu X; Pan S; Li C
    J Periodontal Res; 2018 Jun; 53(3):391-402. PubMed ID: 29315565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular matrix metalloproteinase inducer (EMMPRIN) remodels the extracellular matrix through enhancing matrix metalloproteinases (MMPs) and inhibiting tissue inhibitors of MMPs expression in HPV-positive cervical cancer cells.
    Xu Q; Cao X; Pan J; Ye Y; Xie Y; Ohara N; Ji H
    Eur J Gynaecol Oncol; 2015; 36(5):539-45. PubMed ID: 26513879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma.
    Major TC; Liang L; Lu X; Rosebury W; Bocan TM
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1200-7. PubMed ID: 12117738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upstream regulation of matrix metalloproteinase by EMMPRIN; extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque.
    Yoon YW; Kwon HM; Hwang KC; Choi EY; Hong BK; Kim D; Kim HS; Cho SH; Song KS; Sangiorgi G
    Atherosclerosis; 2005 May; 180(1):37-44. PubMed ID: 15823273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular matrix metalloproteinase inducer in brain ischemia and intracerebral hemorrhage.
    Liu Y; Mu Y; Li Z; Yong VW; Xue M
    Front Immunol; 2022; 13():986469. PubMed ID: 36119117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMMPRIN (CD147/basigin) mediates platelet-monocyte interactions in vivo and augments monocyte recruitment to the vascular wall.
    Schulz C; von Brühl ML; Barocke V; Cullen P; Mayer K; Okrojek R; Steinhart A; Ahmad Z; Kremmer E; Nieswandt B; Frampton J; Massberg S; Schmidt R
    J Thromb Haemost; 2011 May; 9(5):1007-19. PubMed ID: 21320284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EMMPRIN-mediated induction of uterine and vascular matrix metalloproteinases during pregnancy and in response to estrogen and progesterone.
    Dang Y; Li W; Tran V; Khalil RA
    Biochem Pharmacol; 2013 Sep; 86(6):734-47. PubMed ID: 23856290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Invasive Detection of Extracellular Matrix Metalloproteinase Inducer EMMPRIN, a New Therapeutic Target against Atherosclerosis, Inhibited by Endothelial Nitric Oxide.
    Ramirez-Carracedo R; Tesoro L; Hernandez I; Diez-Mata J; Filice M; Toro R; Rodriguez-Piñero M; Zamorano JL; Saura M; Zaragoza C
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of extracellular matrix metalloproteinase inducer (EMMPRIN) and its related extracellular matrix degrading enzymes in the endometrium during estrous cycle and early gestation in cattle.
    Mishra B; Kizaki K; Koshi K; Ushizawa K; Takahashi T; Hosoe M; Sato T; Ito A; Hashizume K
    Reprod Biol Endocrinol; 2010 Jun; 8():60. PubMed ID: 20540754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Matrix Metalloproteinase Inducer EMMPRIN (CD147) in Cardiovascular Disease.
    von Ungern-Sternberg SNI; Zernecke A; Seizer P
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29419744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of extracellular matrix metalloproteinase inducer in the unstable plaque of patients with acute coronary syndrome].
    Wang B; Xu SS; Jiang JJ; Lu XB; Xue YS; Wang JC; Mi YF; Zhu M; Ge WL; Tang LJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):416-20. PubMed ID: 22883094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artemisinin inhibits extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinase-9 expression via a protein kinase Cδ/p38/extracellular signal-regulated kinase pathway in phorbol myristate acetate-induced THP-1 macrophages.
    Wang Y; Huang ZQ; Wang CQ; Wang LS; Meng S; Zhang YC; Chen T; Fan YQ
    Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):11-8. PubMed ID: 21039753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14) cleaves and releases a 22-kDa extracellular matrix metalloproteinase inducer (EMMPRIN) fragment from tumor cells.
    Egawa N; Koshikawa N; Tomari T; Nabeshima K; Isobe T; Seiki M
    J Biol Chem; 2006 Dec; 281(49):37576-85. PubMed ID: 17050542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 18 and extracellular matrix metalloproteinase inducer cross-regulation: implications in acute myocardial infarction.
    Xie SL; Chen YY; Zhang HF; Deng BQ; Shu XR; Su ZZ; Lin YQ; Nie RQ; Wang JF
    Transl Res; 2015 Mar; 165(3):387-95. PubMed ID: 25267095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages.
    Huang Z; Wang L; Meng S; Wang Y; Chen T; Wang C
    Int J Cardiol; 2011 Jan; 146(2):153-8. PubMed ID: 19576641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.